CAMK2G

CAMK2G is a calcium/calmodulin-dependent serine/threonine kinase that transduces Ca2+ signals to control cell differentiation, redox homeostasis, and proliferative signaling across neuronal and non-neuronal tissues (PMID:30184290, PMID:35039634). In neurons it restrains the pace of neurodevelopmental progression, since its loss drives precocious maturation (PMID:30184290), and a calmodulin-coupled mechanism in which PCP4 binds calmodulin to activate CAMK2G autophosphorylation promotes neuronal differentiation (neurite outgrowth, upregulation of NF-H and MAP2) while suppressing migration and invasion (PMID:39266386). Genetic ablation in mice produces specific motor and innate-behavior deficits with little effect on hippocampus-dependent learning or synaptic plasticity, marking a selective role in motor neurodevelopment (PMID:36685241). As a signaling effector, CAMK2G directly senses reactive oxygen species and phosphorylates ITPKB at serine 174 to maintain redox homeostasis and modulate cisplatin resistance in ovarian cancer cells (PMID:35039634), and it functions downstream of MPL-JAK2 signaling, where its activity supports the clonogenic capacity of MPL W515L-expressing bone marrow cells in myelofibrosis (PMID:34521112). The gain-of-function mutation p.Arg292Pro constitutively elevates phosphotransferase activity and impairs nuclear targeting, causing neurodevelopmental defects through aberrant cytosolic kinase activity rather than loss of nuclear localization (PMID:30184290).

1. 1994 Medium

   Establishing the chromosomal location of CAMK2G provided the genomic anchor needed to link the gene to human phenotypes and orthologous mouse studies.

   Evidence Somatic cell hybrid mapping and FISH localizing the human gene to 10q22 and the mouse ortholog to chromosome 14

   PMID:8287681

   Open questions at the time

   • No functional or mechanistic role assigned at this stage
   • Gene structure and isoforms not yet characterized
2. 2002 Low

   Cloning the full gene structure and noting expression in pancreatic beta cells extended CAMK2G's potential role to Ca2+-dependent secretory contexts.

   Evidence PAC library cloning, vectorette PCR, SSCP variant screening, and FISH localization

   PMID:12032636

   Open questions at the time

   • Insulin-secretion role stated from prior knowledge without a new direct experiment
   • No direct kinase or substrate data generated here
3. 2018 Medium

   Linking CAMK2G to human neurodevelopmental disease and defining how a recurrent mutation acts answered whether disease arises from gain or loss of kinase function.

   Evidence Knockdown, catalytic-site silencing, phosphotransferase activity measurement, and neuronal maturation readouts for the p.Arg292Pro variant

   PMID:30184290

   Open questions at the time

   • Cytosolic substrates mediating the maturation phenotype not identified
   • Mechanism of impaired nuclear targeting unresolved
   • Single-lab characterization
4. 2022 Medium

   Identifying ITPKB-S174 as a direct substrate connected CAMK2G to ROS sensing and redox-homeostasis control in cancer cells.

   Evidence Pharmacologic inhibition, in vitro kinase assay, site-specific pS174 detection, and cisplatin-resistance assays in vitro and in vivo

   PMID:35039634

   Open questions at the time

   • How CAMK2G directly senses ROS at the molecular level not defined
   • Generality of ITPKB phosphorylation beyond ovarian cancer untested
5. 2022 Medium

   Placing CAMK2G downstream of MPL-JAK2 signaling established it as a proliferative effector in myelofibrosis.

   Evidence Heterozygous knockout, colony-forming assays, berbamine inhibition, and a myelofibrosis mouse survival model

   PMID:34521112

   Open questions at the time

   • Direct biochemical link between JAK2 and CAMK2G activation not shown
   • Relevant downstream CAMK2G substrates in this context unidentified
6. 2023 Medium

   Behavioral phenotyping of knockout mice distinguished CAMK2G's contribution to motor neurodevelopment from cognitive and synaptic functions.

   Evidence Camk2g knockout mouse motor tests, hippocampus-dependent learning tasks, and synaptic plasticity assays

   PMID:36685241

   Open questions at the time

   • Cellular circuits underlying motor deficits not mapped
   • Molecular targets responsible for behavioral phenotype unknown
7. 2024 Medium

   Defining the PCP4-calmodulin-CAMK2G axis provided a mechanism for how upstream regulators drive CAMK2G activation to promote differentiation and limit invasion.

   Evidence Co-IP, LC-MS/MS identification of CAMK2G as a CaM target, knockdown with RNA-seq, and neurite outgrowth/migration assays in neuroblastoma cells

   PMID:39266386

   Open questions at the time

   • Direct phosphorylation substrates driving differentiation not identified
   • Co-IP not reciprocally validated for the PCP4-CAMK2G interaction
   • Single cell-line context

• The full repertoire of CAMK2G substrates and how Ca2+/calmodulin, ROS, and JAK2 inputs are integrated to govern nuclear versus cytosolic signaling remains unresolved.
• No structural model linking activation inputs to substrate selection
• Determinants of nuclear targeting and its functional consequences unknown
• Substrate set largely limited to ITPKB